Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.
about
Big Data Analytics for Prostate RadiotherapyLate gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreasRadioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveNormal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.Clinical validation of 4-dimensional computed tomography ventilation with pulmonary function test data.Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniquesParotid gland function after radiotherapy: the combined michigan and utrecht experience.A computational tool for the efficient analysis of dose-volume histograms from radiation therapy treatment plans.Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelDosimetric effect of tissue heterogeneity for (125)I prostate implantsComparison of prostate IMRT and VMAT biologically optimised treatment plans.Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?The use of biologically related model (Eclipse) for the intensity-modulated radiation therapy planning of nasopharyngeal carcinomas.Development and evaluation of convergent and accelerated penalized SPECT image reconstruction methods for improved dose-volume histogram estimation in radiopharmaceutical therapy.Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomiaCyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations.Estimation of α/β for late rectal toxicity based on RTOG 94-06Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study.Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complicatiAnalysis of radiation pneumonitis risk using a generalized Lyman model.Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance.Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram dataIncorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.Ranking radiotherapy treatment plans using decision-analytic and heuristic techniques.Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plansPersonalized treatment planning with a model of radiation therapy outcomes for use in multiobjective optimization of IMRT plans for prostate cancerA novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.Monte Carlo Simulations for Dosimetry in Prostate Radiotherapy with Different Intravesical Volumes and Planning Target Volume Margins.Multi-institutional comparison of intensity modulated radiation therapy (IMRT) planning strategies and planning results for nasopharyngeal cancer.A decision aid for intensity-modulated radiation-therapy plan selection in prostate cancer based on a prognostic Bayesian network and a Markov model.Similar-case-based optimization of beam arrangements in stereotactic body radiotherapy for assisting treatment planners.On the impact of functional imaging accuracy on selective boosting IMRTIs it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans.
P2860
Q26744485-D655015E-CABE-4BAA-AB2A-378C9D905873Q26785731-31AC9D2E-54C8-4983-A1C1-6A73CB474F86Q26998661-DA913E5B-D152-4CB7-BD06-0724BD010855Q30402671-8B135898-B9B4-41EF-91B7-804307F700DAQ30918126-EC4AE2A8-FEDF-4575-88D6-AD640148B1B0Q33894885-CF0C9409-F38F-469D-AC55-D940B6D77652Q33927574-36883B4B-D2DD-4B59-8886-D35E5BDA5290Q33961621-9A87BC7A-E7EB-48F0-A703-55BE2FC62EFFQ34161145-32AB0B89-BB2E-44CA-B00A-FBDE434E3555Q34211377-5AD8498A-9226-44A0-AD78-208D2CB651EBQ34238364-E9FF5DEC-78A5-4B4D-8161-94C793015876Q34363645-5BD608A7-57E7-4A05-8AB6-670F0B8AD596Q34372750-C6D1D832-BA20-4DBB-89EC-91BBC9C462B0Q34435278-757159B1-E24B-483C-AAEE-FD787841F820Q34459534-F208D359-7F71-4D1F-AA68-896492E1DFD2Q34563194-258A4D0A-7FC8-457F-9C23-3F57D9BE8B32Q35030231-4B4CCE8B-A0A6-4B81-A166-A3C8A40C9818Q35059298-39E27406-4859-45D5-B861-BF8DE27F44B9Q35186584-02609E87-0F4E-4C8C-ACC5-C8A6CB55C325Q35500065-3B9D3221-80AB-485C-9EF0-09938BB2F853Q35515150-708E44F7-25A2-4E80-A69D-A0348D0427CAQ35669846-615D5E29-1101-4B00-92FA-DD792C761A13Q36124529-DE033C14-FF18-4E21-BAF4-A214098DF8F6Q36145910-CE1E923C-C833-4B16-B27F-44B8B7E63D80Q36235453-E31FF418-2C6D-473D-B0F1-00F2FAE2EAE5Q36235629-4AE081C7-491B-4AA3-98C1-F737BFD6B640Q36356424-ECFA09A3-55A0-441E-B1C3-22E6F5CCC78FQ36374803-4253849C-21B1-4D20-B69C-50931AFC632DQ36397239-5781E4FC-7E31-461A-83F5-332F6ECE9768Q36465589-81291D92-D82E-461C-8DCC-B231A9B14D07Q36468963-E313D376-258A-4D66-9B99-D8811C4957A1Q36493592-C68F24D1-8749-4FEE-A5C4-D9C1E15D4AB6Q36679026-6B345B8B-0D4E-4C04-B01F-4675BFB88489Q36951545-9C3A9555-E1FF-4B38-B22F-1A244B231CB6Q37115558-97DB9028-7622-4A7A-9956-77128654F59AQ37166580-B0B793F6-53AC-4BBD-AECA-67116C984B42Q37198226-8360D368-87F5-4B1D-8E5D-8AD603852D2DQ37330495-7D092E42-2D0A-481A-AF8B-6044989168D0Q37332199-88611981-BB79-4B57-AE1B-2670F3EF5408Q37478420-EE27E8D1-33E0-4490-9D24-1974BB26CABE
P2860
Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Calculation of complication pr ...... : the effective volume method.
@en
type
label
Calculation of complication pr ...... : the effective volume method.
@en
prefLabel
Calculation of complication pr ...... : the effective volume method.
@en
P1476
Calculation of complication pr ...... n: the effective volume method
@en
P2093
P304
P356
10.1016/0360-3016(89)90972-3
P407
P577
1989-06-01T00:00:00Z